
Hematologist-Oncologist
No OPD information available
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Follicular Lymphoma
Non-Hodgkin Lymphoma
Classical Hodgkin Lymphoma
Erythema Multiforme
Gastric Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma (MCL)
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Primary Mediastinal B-Cell Lymphoma (PMBCL)
Scalded Skin Syndrome
Stevens-Johnson Syndrome
Allison A. Barraclough is a medical professional who helps patients with different types of lymphoma, skin conditions, and syndromes. She specializes in treating B-Cell Lymphoma, including Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, and Mantle Cell Lymphoma (MCL). She also works with Non-Hodgkin Lymphoma and Classical Hodgkin Lymphoma.
Allison A. Barraclough is known for her expertise in managing conditions like Erythema Multiforme, Gastric Lymphoma, Scalded Skin Syndrome, and Stevens-Johnson Syndrome. She is skilled in diagnosing and treating these complex health issues.
Patients trust Allison A. Barraclough because she communicates clearly and compassionately with them. She takes the time to explain medical information in a way that is easy to understand. Patients appreciate her caring and empathetic approach to healthcare.
To stay updated with the latest medical knowledge and research, Allison A. Barraclough regularly attends conferences, reads medical journals, and participates in continuing education programs. She is dedicated to providing the best possible care for her patients by staying informed about advancements in the field.
Allison A. Barraclough works collaboratively with colleagues and other medical professionals to ensure comprehensive and effective treatment for her patients. She values teamwork and believes in the importance of a multidisciplinary approach to healthcare.
Through her work, Allison A. Barraclough has positively impacted many patients' lives by providing expert care and support. Her dedication to improving patient outcomes and quality of life is evident in the results she achieves.
One of Allison A. Barraclough's notable publications is "Predicting bispecific antibody failure in diffuse large B-cell lymphoma," which was published in Hematology. She is also involved in a Phase 3 clinical trial studying the effectiveness of a new treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Allison A. Barraclough's commitment to excellence in patient care, ongoing learning, and collaboration with colleagues makes her a trusted and respected healthcare provider in her field.
Enrollment Status: Active not recruiting
Published: April 06, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
